American Cannabis News

Curaleaf Borrows $500 Million for 3 Years at 11.5% – New Cannabis Ventures

Published

3 months ago

February 19, 2026

admin

Curaleaf Borrows $500 Million for 3 Years at 11.5% – New Cannabis Ventures

Curaleaf announces the closing of a private placement of $500 million of 11.5% senior secured notes due 2029.

STAMFORD, Conn., Feb. 19, 2026. /PRNewswire/ — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international supplier of consumer cannabis products, today announced that it has closed a previously announced private placement (the “Offering”) of $500 million in aggregate principal amount of 11.5% due February 2218 (unsecured due 2218). Redemption of $475 million of its previously outstanding notes due December 15, 2026. The Company intends to use the net proceeds from the Offering to provide growth capital to support global growth initiatives and to pay transaction fees and expenses.

The non-dilutive notes, issued at 100% par value, are senior secured obligations of the Company, payable in equal semi-annual installments until maturity, unless earlier redeemed or purchased. The Notes are governed by a trust indenture executed at the closing of the Offering, which permits additional issuances subject to leverage covenants and other conditions, and up to $100 million in senior bank financing.

“The successful closing of this landmark private placement provides a strong endorsement of Curaleaf’s strategy and long-term vision. I am exceptionally proud of our team for delivering the largest bond offering completed in the cannabis industry, expanding the world of institutional investors and strengthening Curaleaf’s leadership position in the industry,” said Chair BorisCE. With an extended runway to 2029 and enhanced capital flexibility, we are well positioned to accelerate our global expansion and capture key strategic opportunities in the international hemp market.

The notes have been offered on a private placement basis in certain Canadian provinces and territories pursuant to applicable exemptions from the prospectus requirements of Canadian securities laws. The Notes were also sold in the United States for the account or benefit of “US persons” (as defined in the United States Securities Act of 1933, as amended (the “US Securities Act”)), on a private placement basis to “qualified institutional buyers” and “accredited investors” pursuant to an exemption from the requirements of the US Securities Registration Act. Under Canadian securities law, the issued securities are subject to a customary four-month hold period.

Seaport Global Securities, LLC acted as lead underwriting agent and ATB Cormark Capital Markets (the “Agents”) acted as co-underwriting agent for the Notes in the United States and Canada, respectively.

No securities regulatory authority has approved or disapproved the content of this news release. The Notes have not been and will not be registered under the US Securities Act or state securities laws. Accordingly, the notes have not been offered or sold in the United States or for the account or benefit of “US persons” except as registered under the US Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the US Securities Act and applicable state securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy securities of the Company in any jurisdiction where such offer, solicitation or sale would be illegal.

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer cannabis products with a mission to improve lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find and Anthem, provide industry-leading service, product selection and access to the medical and adult use markets. Curaleaf International is powered by a strong presence at all stages of the supply chain. Its unique distribution network across Europe, Canada and Australasia combines advanced science and research with advanced cultivation, extraction and manufacturing. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX under the symbol CURLF. For more information, visit https://ir.curaleaf.com.

Original press release

Published by NCV Newswire

New Cannabis Ventures’ NCV Newswire aims to gather high-quality content and information about leading cannabis companies to help our readers filter through the noise and stay on top of the most important cannabis business news. The NCV Newswire is edited by an editor and is not, however, automated. Got a secret news tip? Get in touch.

Related Topics:Borrows Cannabis Curaleaf Million Ventures years

Up Next

Michigan Cannabis Sales Plunged to Begin 2026 – New Cannabis Ventures

Don't Miss

Big Cannabis Companies Are Set to Report Q4 Financials – New Cannabis Ventures

aawh

Michigan Cannabis Sales Fell Yet Again – New Cannabis Ventures

Published

2 days ago

May 13, 2026

admin

Michigan Cannabis Sales Fell Yet Again – New Cannabis Ventures

Michigan April hemp sale decreased compared to a year ago, as they increased sequentially by 1.2%. At $258.6 million, sales decreased by 4.3 percent compared to last year.

Michigan’s cannabis regulatory agency breaks down sales by medical and adult use, with medical sales down 24.1% year-over-year to $0.4 million, down 5.6% sequentially, and adult-use sales down 4.3% year-over-year to $255.5 million, despite a one-day increase of 1.2% in March.

The state breaks down sales by category and provides pricing details by category for both medical and adult;

280E

Cannabis Stocks Are Going Nowhere Quickly – New Cannabis Ventures

Published

1 week ago

May 7, 2026

admin

Cannabis Stocks Are Going Nowhere Quickly – New Cannabis Ventures

You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.

friends,

The New Cannabis Ventures Global Cannabis Stock Index edged up slightly in May, rising 1.1% to 5.76. Compared to the previous year, it decreased by 12.6%. The index, recalculated as of the end of the first quarter, is up 9.9% so far in the second quarter, lagging the S&P 500’s 12.8% gain. Here are the earnings of the 23 names currently in the index (SMG was dropped in late April after the sale of Hawthorne Gardening):

MSOs are very much higher as the rally approaches the discussion of the big transformation announcements on 4/22 and beyond. There are currently six MSOs and two of them have been promoted. The rest rose, and the average of the six was 38.1%. The AdvisorShares Pure US Cannabis ETF ( MSOS ) has rallied 48.5% since the end of March and is now up 11.7% year-to-date in 2026. Both GCSI names have fallen sharply, and the index has a total of seven double-digit gains in Q2, with six MSOs and Canopy holding investments. 14 of the 23 names returned less than GCSI.

As readers are probably aware, the US reclassified medical cannabis from Schedule I to Schedule III on 4/23, and that will go away. 280E tax for some of the businesses of cannabis companies. The Department of Justice will hold a hearing in late June to determine possible rezoning for adult use. If it passes, all 280E taxation will end, which is a good thing for cannabis companies and their investors, as well as the subsidiaries that serve them. It is not yet known what the outcome will be, and it is not yet known how past 280E taxes that have not been paid but are carried as liabilities (and not debt) will be handled. Also, there is no conclusion yet on SECURITY banking or the possibility of a raise.

NCV has stopped publishing news, although we continue to update the financial calendar as well as the earnings rankings. After more than 10 years with NCV and more than a dozen years with 420 Investor, I am in the process of moving on. I’ve appreciated sharing the news and my views here, and I want to wish everyone the best. Hopefully, the 280E taxation will end and the bear market that started in early 2021 for the hemp sector will come to an end.

Sincerely,

Alan:

This week’s newsletter is sponsored by the Paul E. Saperstein Co.

Massachusetts hemp production equipment for sale

On May 12, Middlesex Integrative Medicine, Inc.’s equipment is being auctioned online in Leominster, Massachusetts at 10:00 a.m. ET. All applications must be submitted online. Learn more Of the secured party’s sale of all assets of this cultivation equipment.

Interested parties may contact Paul Cotto at 617-227-6553 or email pcotto@pesco.com:.

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 2 weeks.

Exclusives

Sales of Canadian hemp continued in February

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

ACB

Few Care About This Large Cannabis Operator – New Cannabis Ventures

Published

4 weeks ago

April 17, 2026

admin

Few Care About This Large Cannabis Operator – New Cannabis Ventures

friends,

Just before Christmas, this newsletter discussed how Vireo Growth is getting pretty big. At the end of January I profiled how Vireo Growth is expanding its business. This week’s newsletters include six articles we’ve run since April 2, and Vireo Growth is central to two of them. Vireo Growth is big and getting bigger, but few people seem to care.

I’m not writing this to tell readers to care. In fact, while I used to include the company on my Focus List at 420 Investor, I no longer do. Earlier this month I wrote an article for my subscribers about why I keep looking at things but not including stocks in my Focus List. Here is the summary.

I watch VREOF because it is now one of the largest MSOs by revenue, but it continues to fall short of joining the Global Hemp Stock Index due to its low trading volumes. Average daily trading volume over the past month was 251,000 shares, which is about $100,000 in daily trading value. This is well below peers. Perhaps more importantly, the current price of $0.45, which is down 26.6% year-to-date, is significantly lower than the price of $0.625 for the last large cap in 2024. Not only are the investors not winning, but VREOF hsa distributed a lot of shares to the sellers and they are also under water.

Maybe Vireo Growth shares will reward their owners, or maybe it will continue to do so. I think hemp stock investors and debt holders should be asking why no one is thinking of this yet. Scotts Miracle-Gro, which has been public since 1992 and has a market cap of $3.6 billion, picked up much of VREOF’s stock when it spun off Hawthorne. The 213 million shares are “at an implied price of $0.60” per share, although VREOF hasn’t traded at $0.60 since January. When the divestiture was announced in late January, Vireo Growth closed at $0.5553.

So a large MSO that has reshuffled its management, is now in multiple markets, and has executed its plan to get bigger with several acquisitions, is still not responding to the cannabis investment community. I wish them the best.

Sincerely,

Alan:

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 2 weeks.

Exclusives

The sale of hemp did not succeed until March

Michigan’s hemp sales are down again

Mergers and acquisitions

Aurora Cannabis acquires Cultivator for C$26.5 million

Greenhouse Brands and Vireo Growth Weak in California Cannabis Combination

Organigram Global Closes European Acquisition

Vireo Growth acquires Hawthorne Gardening Company

Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.